RVMD · Revolution Medicines, Inc. · Investor Relations
$195.78
+13.63 (+7.48%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$39.04B
Shares
214.34M
Volume · Oct 20
2.73M
Avg daily vol (3M)
1.98M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-26 | RASONQUE FDA Approval Investor Update | Event |
| 2026-08-05 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-31 | Revolution Medicines Conference Call | Conference |
| 2026-05-06 | Revolution Medicines Q1 2026 Earnings Conference Call | Earnings call |
| 2026-02-25 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.revmed.com/
Key facts
CIK
1628171
CUSIP
76155X100
13F (30d)
96 filings
91 filers
Visit website
Investor relations